Leukemia deaths jumped in Japan in 2022 after the mRNA jabs, reversing years of declines

Overall cancer deaths in Japan stayed flat. Still, the uptick in leukemia deaths is a signal worth noting, especially since blood cancers are the malignancies mRNAs are most likely to impact.

Leukemia deaths surged 6 percent in Japan in 2022, ending a long downward trend and reaching their highest level in over a decade, Japanese researchers reported.

Breast cancers also rose sharply in 2022, the researchers found. Overall deaths from all cancers were flat in 2021 and 2022, a change after years of falling age-adjusted death rates.

Japan has one of the world’s highest mRNA vaccination rates. Nearly everyone over 70 received the first two shots, mostly Pfizer. Almost 95 percent got at least one booster.

Some mRNA skeptics argue the shots are causing sharp increases in cancer deaths and what they call “turbo cancers” – very aggressive tumors. Those claims usually come from anecdotes or estimates of cancer incidence, rather than actual cases.

This paper is among the first to offer a signal based on national-level data showing a real rise in deaths from some cancers, though it doesn’t prove the jabs caused them.

Share
Scroll to Top